The QualityStocks Daily Wednesday, August 14th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (CTAM) +282.51%

NetworkNewsWire (RNWR) +32.96%

SmallCapRelations (SGSI) +29.87%

The QualityStocks Daily Stock List

ProtoKinetix, Incorporated (PKTX)

Allstocks, Investor Village, ResearchPool, OTC PR Group, Trading View, 4-Traders, Wallet Investor, and Stockwatch reported previously on ProtoKinetix, Incorporated (PKTX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Incorporated provides medical researchers with a platform for enhancing cell survival and health, in vitro and in vivo. A molecular biotechnology company, it has developed and patented a family of hyper stable, potent glycopeptides (AAGP®) that enhance engraftment and protection of transplanted cells, organs, tissues and organs used in regenerative medicine. ProtoKinetix has its corporate office in Marietta, Ohio. The Company lists on the OTC Markets’ OTCQB.

At the core of ProtoKinetix’s technology is its patented anti-aging glycopeptide AAGP™. This small molecule (580 Daltons) displays abilities in resolving challenges facing medical researchers in areas such as regenerative medicine and as a therapy for diseases relating to tissue inflammation and oxidation stress. Because of its stability, small size and molecular makeup, it maintains its function in vivo without triggering the body's immune system. It can also function without toxic side effects common in treatments involving larger and less stable compounds.

ProtoKinetix is building value through the independent research of laboratories, university and private, into applications for its AAGP™ molecule. Pertaining to health solutions, there are two primary categories that AAGP™ applications would be divided into. One is regenerative Medicine issues. This includes harvesting, processing, storage and transplanting cells, tissues and organs. The other is treatments for chronic inflammatory conditions and diseases caused by stress factors. This includes UV radiation, oxidation, and cryopreservation and hydrogen cyanide.

Due to the results achieved over the last four years of testing, the University of Alberta has commenced Phase 1 human clinical trials. Additional studies will be expanded to include whole organ transplantation and all therapies that are being developed globally to date; diabetes, retinal degeneration, cardiac repair and manifold other degenerative conditions. In addition, ProtoKinetix is studying the potential impact on several cancer therapies.

Recently, ProtoKinetix announced it reached the mid-point of 3rd stage of testing in retinal cell replacement therapy at the University of British Columbia. The Company stated that functionality testing on experimental models three months post-transplant show encouraging results. The study includes two experimental models over a longer period of time to test whether the AAGP® treated cells continue to develop and mature into retinal cells to potentially restore vision in humans. The Gregory-Evans Retinal Therapeutic Lab at the University of British Columbia is conducting the study.

ProtoKinetix, Incorporated (PKTX), closed Wednesday's trading session at $0.2002, off by 9.00%, on 24,176 volume with 9 trades. The average volume for the last 3 months is 184,499 and the stock's 52-week low/high is $0.05/$0.319999992.

chart

Iota Communications, Inc. (IOTC)

Wall Street Reporter, Zacks, Market Wire News, Street Insider, Whale Wisdom, Real Investment Advice, Last10k, Wallet Investor, Stockopedia, Investing.com, Stockhouse, TradingView, InvestorsHub, PR Newswire, Investors Hangout, Stockwatch, and Market Screener reported previously on Iota Communications, Inc. (IOTC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Iota Communications, Inc. is a wireless network carrier and software service company listed on the OTCQB. It provides Internet of Things (IoT) solutions that optimize energy efficiency, sustainability, and operations for commercial facilities. The Company provides data-driven insights for sustainability enabled by its network connectivity, advanced analytics platform, and software-as-a-service (SaaS) solutions for commercial and industrial markets throughout the United States. Iota Communications has its corporate headquarters in New Hope, Pennsylvania.

In addition, Iota Communications offers important ancillary products and services that facilitate the adoption of its subscription-based services. This includes solar energy, LED lighting, as well as HVAC implementation services. Fundamentally, the Company uses technology and connectivity to help businesses save money and become more sustainable.

Regarding Connecting, using its own 800 MHz FCC-licensed spectrum and multi-access gateways, Iota’s network is purpose built for the IoT. It offers superior building penetration, more reliable coverage, and secure data transmission. Concerning Collecting, easy-to-install wireless sensors, meters and devices unlock valuable data from an organization’s existing infrastructure (Mechanical, Electrical and Environmental). This provides visibility into a company’s facility operations.

Pertaining to Analysis, Iota Communications’ BrightAI platform gives an organization the insights and alerts to boost operational visibility and proactively manage their facility. Therefore, a company can identify opportunities, improve performance, and also share insights across teams and organizations. Regarding Optimization, Iota’s platform (combining data and analytics) provides a continuous feedback loop. This optimizes energy efficiency, improves the performance of a firm’s operations, and drives considerable savings for a facility.

Recently, Iota Communications announced that its wholly-owned subsidiary, Iota Commercial Solutions, completed and commissioned a ground mounted solar array at the new Belair K-8 School in Augusta, Georgia. The 336-kilowatt (DC) system consists of 988 solar photovoltaic modules. It is estimated to generate greater than 500 megawatt-hours in the first year of operation. This equates to enough power for more than 50 homes annually.

Last month, Iota Communications announced the closing of the Spectrum Partners Program and simultaneous launch of Iota Spectrum Partners, LP, an Arizona Limited Partnership (Iota Partners), to consolidate exclusive FCC Radio Spectrum Authorizations presently owned and leased by Iota Networks, LLC (Iota Networks), a wholly-owned subsidiary of Iota Communications.

Iota Communications Chief Executive Officer & President, Mr. Terrence DeFranco, said, “Iota is creating the first purpose built, nationwide wireless network carrier system dedicated to the rapidly emerging Internet of Things industry. By employing FCC-licensed 800 MHz radio spectrum, we believe we will have a significant competitive advantage over cellular and unlicensed spectrum IoT solutions, long range and low infrastructure cost, improved building penetration, low power consumption, and intrinsic security and reliability…”

Iota Communications, Inc. (IOTC), closed Wednesday's trading session at $0.40, off by 0.348779%, on 328,089 volume with 42 trades. The average volume for the last 3 months is 82,653 and the stock's 52-week low/high is $0.305000007/$1.26999998.

chart

Parallax Health Sciences, Inc. (PRLX)

Market Screener, Last10k, Wallmine, 4-Traders, PR Newswire, Simply Wall St, Wallet Investor, Stockwatch, Proactive Investors, TMX Money, TradingView, InvestorsHub, Stockhouse, and GlobeNewswire reported earlier on Parallax Health Sciences, Inc. (PRLX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Parallax Health Sciences, Inc. is an outcome-driven connected healthcare company listed on the OTCQB. It allows for cost-effective remote diagnosis, treatment and monitoring of patients via proprietary platforms of integrated products and services. Parallax’s products and offerings capitalize on the digital transformation in healthcare for improved patient compliance, diagnosis and treatment, and support healthcare system cost savings and efficiencies. The Company previously went by the name Endeavor Power Corporation. It changed its name to Parallax Health Sciences, Inc. in January of 2014. Parallax Health Sciences has its head office in Santa Monica, California.

The Company concentrates on personalized patient healthcare via its wholly owned subsidiaries, Parallax Health Management, Parallax Behavioral Health, and Parallax Diagnostics. Parallax’s interoperable novel applications provide patients point-of-care testing and monitoring with information communicated through internet-based mobile phone applications, which are agnostic as to operating system. They are constructed on highly sophisticated data analytics.

Information is retrieved real-time by physicians who are monitoring patients with chronic diseases or via biometric feedback for health-related behavior modification. Information is automated for integration into electronic health records.

Regarding Parallax Diagnostics, Parallax's Target Antigen Detection System (TADS) Diagnostic Platform is a Controlled Flow-Through Rapid Immunoassay Technology. It offers a variety of improved modifications and features to the traditional Flow-Through Immunoassay Test. With its Platform uniformity, vacuum pump, absorption layer for sample overflow, and complete compatibility with the Company’s optic reader, the Target System Diagnostics Platform is an inventive collection of tests for qualitative and quantitative detection of patient conditions.

Parallax Behavioral Health (PBH) provides consulting and software solutions to businesses and individuals. This is to improve value, margin, and performance by way of enhanced outcomes and lower cost mastery. PBH has its patented Intrinsic Code. It encompasses predictive - progressive analytics and goal optimization software. PBH is strategically positioned to enable users from large healthcare corporations to individuals take control of their outcomes.

Parallax Health Management offers remote monitoring solutions. These solutions are to support disease management and provide better care options for chronic conditions.

In July, Parallax Health Sciences announced it entered into a strategic license agreement with HealthPointe Solutions, a provider of health and wellness solutions powered by cognitive artificial intelligence, (Cognitive AI). HealthPointe’s Cognitive AI solutions powers understanding across a broad array of healthcare analytics and drives value-based outcomes.

Mr. Paul Arena, Parallax Health Sciences’ Chief Executive Officer, stated, “HealthPointe Solutions is powered by Cyc, the worlds longest-lived artificial intelligence platform, and other advance Artificial Intelligence engines and knowledge bases in turn making HealthPointe Solutions the ideal partner to integrate with the Parallax Care Platform. HealthPointe Solutions shares our mission to reduce costs, increase access, and improve outcomes for patients and allow providers to deliver better outcomes.”

Parallax Health Sciences, Inc. (PRLX), closed Wednesday's trading session at $0.11, off by 13.7255%, on 501,700 volume with 12 trades. The average volume for the last 3 months is 82,653 and the stock's 52-week low/high is $0.054000001/$0.300000011.

chart

School Specialty, Inc. (SCOO)

NetworkNewsWire, Zacks, MarketWatch, Capital Cube, Wallet Investor, GlobeNewswire, MarketBeat, Wallmine, Trading View, Simply Wall St, Stockhouse, and Morningstar reported earlier on School Specialty, Inc. (SCOO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

School Specialty, Inc. is a leading provider of innovative products and solutions that support integrated learning environments for improved student social, emotional, mental and physical well-being. The OTCQB-listed Company serves teachers, curriculum specialists, individual schools, school districts, parents, and administrators in diverse healthcare related markets. Established in 1959, School Specialty is based in Greenville, Wisconsin.

School Specialty serves the U.S. and Canada via a comprehensive network of distribution centers powered by a multi-channel approach. The Company designs, develops and delivers the broadest variety of unique and proprietary products, programs and services to the education marketplace. These include essential classroom supplies, furniture, educational technology, supplemental learning resources, science-based curriculum, and evidence-based safety training & security.

School Specialty offers its own proprietary products from best-in-class brands like Sax, SSI Guardian, Frey, Foss and School Smart, as well as some of the most trusted third-party brands in the educational marketplace. School Specialty has grown into a company that includes more than 70 subject matter experts and other industry thought leaders always seeking out and sharing pioneering ideas to advance contemporary education.

This week, School Specialty provided results for its fiscal Q2 ended June 29, 2019. Revenue was $160.6 million for the quarter ended June 29, 2019, versus $169.2 million in Q2 of fiscal 2018. This represents a decrease of 5.1 percent. The decrease included declines of 3.6 percent in the Distribution segment and 22.2 percent in the Science Curriculum segment.

School Specialty reported Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization (Adjusted EBITDA) of $10.3 million for the quarter ended June 29, 2019, versus $11.5 million in the quarter ended June 30, 2018.

Mr. Ryan M. Bohr, Executive Vice President and Chief Operating Officer, stated, “From an operations perspective, the challenges of 2018 are fully behind us. The performance in our fulfillment centers has been exceptional with respect to all customer-facing metrics, such as fill-rates, order lead-times, and order accuracy. We believe this solid execution will be a significant advantage as we look to drive follow-on orders and strengthen order trends after the peak ordering months of July and August.”

School Specialty, Inc. (SCOO), closed Wednesday's trading session at $3.25, off by 7.1429%, on 5,186 volume with 13 trades. The average volume for the last 3 months is 1,396 and the stock's 52-week low/high is $3.17499995/$18.3899993.

chart

Sono-Tek Corporation (SOTK)

Zacks, Micro Small Cap, Capital Cube, Simply Wall St, Street Insider, Silicon Investor, Stockwatch, Whale Wisdom, InvestorsHub, Information Vine, OTC Markets, and Wallet Investor reported beforehand on Sono-Tek Corporation (SOTK), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets worldwide. The Company is the foremost developer and manufacturer of ultrasonic coating systems. Its solutions are environmentally-friendly, efficient, and highly reliable. Sono-Tek is headquartered in Milton, New York.

The Company develops and manufactures ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for varied markets. This includes specialized glass applications in construction and automotive. Sono-Tek’s solutions enable considerable reductions in overspray, savings in raw material, water and energy usage. In addition, they provide improved process repeatability, transfer efficiency, high uniformity, as well as reduced emissions.

Sono-Tek’s unique, patented coating systems provide comprehensive solutions to complex and diverse coating challenges in an array of global industries, from research and development (R&D) through high volume production. All of Sono-Tek’s ultrasonic coating systems integrate Sono-Tek ultrasonic nozzles, liquid delivery, and full system controls. Machines range from R&D tabletop systems, standalone fully enclosed programmable systems, and wide area continuous production inline systems.

Last month, Sono-Tek reported financial results for its Q1 ended May 31, 2019 (Fiscal 2020). The Company had a record high backlog of $4,024,000. Q1 Gross Margin was 46 percent. Sono-Tek achieved Net Income of $25,000, up 19 percent. Sono-Tek expects Q2 Revenues to increase 15-20 percent in comparison to last year. It also expects further growth in Q3.

Sono-Tek’s Net Sales growth was propelled by a combination of increases in the Electronics/Microelectronics market (up 16 percent), the Alternative Energy market (up 118 percent), and the Emerging R&D market (up 68 percent). In Q1 of fiscal 2020, about 56 percent of sales originated outside of the U.S. and Canada versus 63 percent in the prior-year period. This geographic shift reflects higher sales to U.S. markets supported by robust economic growth in the U.S. combined with a decrease in APAC as the Chinese trade situation is sorted out.

Recently, Sono-Tek announced a business development project to expand its Milton, New York facilities with participation and financial incentives from Empire State Development (ESD) and Central Hudson Gas & Electric grants. The proposed expansion planned by the Company will comprise renovations to change existing warehouse/office space over to high-technology manufacturing facilities. The anticipation is that the total project will cost between $550,000 and $650,000. It will result in the creation of six new, full-time employment positions in various high-technology areas of Sono-Tek.

Sono-Tek Corporation (SOTK), closed Wednesday's trading session at $2.59, off by 5.4745%, on 2,600 volume with 2 trades. The average volume for the last 3 months is 2,847 and the stock's 52-week low/high is $1.89999997/$3.0999999.

chart

Top Ships, Inc. (TOPS)

Stocktwits, Zacks, Micro Small Cap, Market Screener, US Post News, GlobeNewswire, Stock Street News, TMX Money, MacroTrends, Stockopedia, 4-Traders, StockInvest.us, Wallet Investor, TradingView, Simply Wall St, Investing.com, and Stockhouse reported beforehand on Top Ships, Inc. (TOPS), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Top Ships, Inc. is a worldwide owner and operator of modern, fuel efficient “ECO” tanker vessels. At present, the Company is focusing on the transportation of crude oil and petroleum products. Its business strategy is to grow its fleet by way of acquisitions of newbuilding, resale or second-hand vessels of top-quality ECO design. Incorporated in the Republic of The Marshall Islands, Top Ships has its headquarters in Marousi, Greece. The Company also has a London and Monaco office.

Top Ships’ Management Team consists of executives with wide-ranging experience in managing and operating large and diversified fleets of vessels, and with strong ties to several national, regional and international oil companies, charterers and traders. Its Management Team has 94 years of combined shipping experience. The Company has a high specification ECO design fleet. All vessels are fitted with Ballast Water Treatment Systems and part of the fleet is fitted with Scrubbers.

This past May, Top Ships announced that it took delivery of the 157,000 dwt (deadweight tonnage) newbuilding Suezmax vessel M/T Eco Beverly Hills, built at the Hyundai Samho shipyard in South Korea.

Mr. Evangelos Pistiolis, President, Chief Executive Officer and Director of Top Ships, said, “The M/T Beverly Hills is the 14th vessel of our fleet (including our two joint venture vessels) and is one of the first scrubber fitted Suezmax vessels to be delivered worldwide. As of today, the total tonnage of our fleet on the water is 892,000 deadweight tonnes and has an average age of two years…”

Last month, Top Ships announced that it concluded a Financing Agreement with a major Chinese Financier. The gross proceeds from the new financing amount to $25.6m. This will be used primarily to refinance the facility of M/T Stena Weco Excellence with Nord LB. The tenor of this new facility is 10 years.

Furthermore, Top Ships announced that it intends to enter into two additional Financing Agreements with the same financier at similar terms. This is to exercise its purchase options for the M/Ts Stena Weco Energy and Stena Weco Evolution. The expectation is that these acquisitions will be concluded during Q4 of 2019.

Top Ships, Inc. (TOPS), closed Wednesday's trading session at $0.3538, up 0.340329%, on 334,564 volume with 718 trades. The average volume for the last 3 months is 605,368 and the stock's 52-week low/high is $0.330000013/$2.70000004.

chart

Tree of Knowledge International Corp. (TOKIF)

CannabisMarketCap, Stock Target Advisor, Investor Ideas, InvestorX, Market Screener, TradingView, Wallet Investor, Investing.com, Investors Hangout, Otc.watch, Stockwatch, Dividend Investor, InvestorsHub, Stockhouse, and GlobeNewswire reported earlier on Tree of Knowledge International Corp. (TOKIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tree of Knowledge International Corp. focuses on the development, processing and manufacturing of high-quality cannabinoid (CBD) products. The OTCQB-listed Company provides a varied range of goods that include medicinals, nutraceuticals, cosmetics, food, beverage, and veterinary products. Tree of Knowledge International has its headquarters in Toronto, Ontario and operations in North York, Ontario, and Spokane, Washington.

Tree of Knowledge derives all its products from natural cannabis and hemp using a state-of-the-art process that is as close to the source as possible. The Company’s CBD product line contains EVR Premium Hemp Oil. This is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States.

At present, Tree of Knowledge has three main business segments. One is multidisciplinary specialty pain clinics with an emphasis on the treatment of chronic pain. This includes controlled applications of medical cannabis in Canada.

A second segment is the development of formulated products for therapeutic purposes and natural health product alternatives at its manufacturing facility in Spokane, which provides formulations for its products and for third parties equivalent to GMP standards. The third segment is the distribution and sale of hemp-based cannabidiol (CBD) products in the U.S., Canada, Europe, Brazil and Australia.

Tree of Knowledge has developed and implemented MCERP (Medical Cannabis Education, Research and Best Practice Platform) and MCORP (Medical Cannabis Opioid Reduction Program) with considerable success. The Company currently has research agreements with numerous universities for medical cannabis research and new medical grade products development.

In July, Tree of Knowledge International announced that it executed a binding Letter of Intent (LOI) for an International Distribution Agreement (IDA) with Cannenta Clinic Corp. (CCC), expanding reach into new markets for the Company into Australia and New Zealand. With this agreement, Tree of Knowledge will supply an initial order of 1,000 units of CBD products for importation to Australia to be distributed to appropriate patients processed via Cannenta’s VEP approved by physician prescriptions.

Cannenta has developed an online discovery and networking program. It enables patients through consultation to address their needs and connect with physicians and licensed producers for the supply of CBD and other medical cannabis products.

Yesterday, Tree of Knowledge International announced it entered into an LOI for an investment in LYTE Clinics, to include the acquisition by the Company of 25 percent of shares in LYTE. LYTE is a foremost medical cannabis tele-health company. It serves patients across nine Canadian provinces via LYTE Resource Centre. LYTE meets medical cannabis needs, granting authorization and offering access to 22 Health Canada-approved licensed producers as part of a same-day service.

Tree of Knowledge International Corp. (TOKIF), closed Wednesday's trading session at $0.0491, even for the day. The stock's 52-week low/high is $0.019999999/$0.629999995.

chart

H/Cell Energy Corporation (HCCC)

Financial Buzz, OTC Markets, Street Insider, Morningstar 4-Traders, Stockwatch, Uptick Newswire, Marketbeat, Market Screener, Simply Wall St, Stockhouse, and Wallet Investor reported previously on H/Cell Energy Corporation (HCCC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

H/Cell Energy Corporation designs and implements clean energy solutions featuring hydrogen and fuel cell technology. The Company is an integrator that centers on the design and implementation of clean energy solutions. This includes solar, battery, fuel cell and hydrogen generation systems. By way of its subsidiaries, it also provides environmental systems and security systems integration. OTCQB-listed, H/Cell Energy is based in Dallas, Texas.

H/Cell serves the residential, commercial, as well as government sectors. It has developed and implemented a hydrogen energy system used to completely power a residence or commercial property with clean energy. This is so it can run independent of the utility grid and also provide energy to the utility grid for monetary credits. This inventive system utilizes renewable energy as its source for hydrogen production.

The HC-1 system is totally scalable. Upon installation, the HC-1 system operates as a self-sustaining energy system providing electricity and/or hydrogen fuel for transportation.

The design of the HC-1 system is to provide clean energy for a better environment. The system eliminates the electric bill and dependence on fossil fuels. Furthermore, this system allows one to benefit with tax and energy credits while helping make the environment safe for future generations. H/Cell Energy’s completed systems include the De Tiberge Property in Pennington, New Jersey and the Strizki Property in Hopewell, New Jersey.

Recently, H/Cell Energy announced that it entered into an equity purchase agreement with GHS Investments LLC (GHS). This agreement will provide the Company access to capital over a 24 month period.

Mr. Andrew Hidalgo, H/Cell Energy Chief Executive Officer, said, "We are very pleased to come to terms with GHS. We have reviewed many proposals for equity investments over the last year, most of which were unsuitable. However, we found GHS to be professional, competent and flexible in constructing an equity investment arrangement that we believe is beneficial to our shareholders. We intend to use any proceeds for growth initiatives as we continue to focus on building shareholder value.”

H/Cell Energy Corporation (HCCC), closed Wednesday's trading session at $1.24, up 90.7692%, on 2,000 volume with 2 trades. The average volume for the last 3 months is 522 and the stock's 52-week low/high is $0.510500013/$1.60000002.

chart

Cardax, Inc. (CDXI)

Zacks, Street Insider, The Street, 4-Traders, Stockopedia, Morningstar, InvestorsHub, Market Exclusive, MarketWatch, GuruFocus, last10k, Barchart, Stockhouse, and Street Insider reported earlier on Cardax, Inc. (CDXI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cardax, Inc. is a development stage Life Sciences Company listed on the OTCQB. It dedicates primarily all its efforts to developing consumer health and pharmaceutical products that it believes will provide many of the anti-inflammatory benefits of steroids or NSAIDS through targeting many of the same inflammatory pathways and mediators, however with exceptional safety profiles. Cardax has its corporate headquarters in Honolulu, Hawaii.

The Company is preparing proprietary nature-identical products and related derivatives via total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated. This includes, but is not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease.

Cardax’s initial main focus is its astaxanthin technologies. Astaxanthin is a strong and safe, naturally occurring, anti-inflammatory and anti-oxidant without the adverse side effects characteristic of anti-inflammatory treatments using steroids or NSAIDS (including immune system suppression, liver damage, cardiovascular disease risk, and gastrointestinal bleeding).

The Company’s ZanthoSyn® is its first product to help consumers safely address their inflammatory health. Cardax says that ZanthoSyn® is a physician recommended, anti-inflammatory supplement for health and longevity that features astaxanthin with optimal absorption and purity. ZanthoSyn® contains astaxanthin, which is Generally Recognized as Safe (GRAS) according to Food and Drug Administration (FDA) regulations. The safety and efficacy of the Company’s product candidates have not been directly evaluated in clinical trials or confirmed by the FDA.

This past October, Cardax announced it launched its Cardiovascular Health Astaxanthin Supplement Evaluation (CHASE) clinical trial targeting cardiovascular inflammatory health. The first subject was dosed on September 19, 2018. This randomized, double-blind, placebo-controlled CHASE clinical trial will evaluate the effect of low-dose and high-dose ZanthoSyn® on cardiovascular health, as measured by C-Reactive Protein (CRP) levels, over 12 weeks in up to 360 subjects with documented cardiovascular risk factors. Additionally, the study will include an optional open label extension through 48 weeks.

In December 2018, Cardax and GNC announced that they are expanding the sales and marketing program for ZanthoSyn®. GNC is the exclusive brick-and-mortar retail channel for ZanthoSyn®. GNC will augment Cardax's sales and marketing efforts with additional initiatives to boost ZanthoSyn® product awareness and education among GNC store associates and customers nationwide.

Cardax, Inc. (CDXI), closed Wednesday's trading session at $0.102, off by 0.097943%, on 14,058 volume with 4 trades. The average volume for the last 3 months is 35,906 and the stock's 52-week low/high is $0.071999996/$0.219999998.

chart

PUDO, Inc. (PDPTF)

Penny Stock Tweets, Stockwatch, Capital Cube, Financial Content, MarketWatch, Infront Analytics, YCharts, The Street, InvestorsHub, Market Screener, Stockreads, Penny Stock Hub, GuruFocus, Investorx, The Wall Street Analyzer, Stockhouse, Morningstar, Wallet Investor, Barchart, Otc.watch, and 4-Traders reported earlier on PUDO, Inc. (PDPTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

PUDO, Inc. is North America's first carrier-neutral Pick-Up Drop-Off Network. It is developing North America's only carrier-neutral parcel pick-up/drop-off technology and logistics network as a way of solving the last-mile parcel-traffic-control gridlock. Recently, the Company was named one of the Top 20 most innovative public technology companies by the Canadian Innovation Exchange. Established in 2015, PUDO is headquartered in Mississauga, Ontario.

PUDO’s team of logistics and parcel traffic management experts have created a market intelligence and trends driven solution. This comprises carrier-neutral plug-and-play technology for desktop and mobile, plus a strategically located network of parcel pick-up and drop-off PUDOpoints for pay-as-you-go use by all players within the e-commerce environment.

The Company's technology and network virtually eliminates expenses associated with second-attempt deliveries, un-attended parcel theft and spoilage, and mismanaged reverse logistics on returns. PUDO’s technology and network provides carriers, retailers, and consumers with needed cost controls, choice, and convenience.

A PUDO Point™ is a convenience store usually within minutes of one’s location. It will accept one’s shipments for them and be there when they are ready to pick them up. There are thousands of PUDO-authorized dealer pickup and drop-off locations across the U.S. and Canada.

Concerning e-commerce and return logistics, PUDO offers complete and cost-effective return logistics programs for its eRetailers and corporations. The Company has a distributed and remote work force across the U.S. and Canada.

PUDO has signed an Agreement with global third-party logistics company Landmark Global, Inc. (LGI), part of the bpost group, to undertake a mutually beneficial arrangement for LGI and its customers to use PUDO's Network of parcel pick-up and drop-off locations, to enhance the last-mile e-commerce parcel delivery experience in Canada on Landmark Global's new Sprintstar network. Using the PUDO network of services, Landmark Global will be able to expand its Sprintstar service to many communities not previously served.

Recently, PUDO announced that it filed interim financial results (unaudited) and operational highlights for its Q3 ended November 30, 2018 . The Company stated that it has gained considerable ground during this period in keeping with its refined emphasis on strategic key markets and partners capable of facilitating exponential growth.

Parcel volumes for the quarter ended November 30, 2018 increased a significant 16.9 percent more than the equivalent quarter the prior year. Parcel volumes in Q3 FY 2019 increased 27.6 percent from those in Q2 FY 2019. During FY 2018, the change in parcel volumes between Q2 and Q3 comprised a 10.4 percent increase.

PUDO, Inc. (PDPTF), closed Wednesday's trading session at $0.583, up 65.2494%, on 100 volume with 1 trade. The average volume for the last 3 months is 495 and the stock's 52-week low/high is $0.128000006/$1.23000001.

chart

Nautilus Minerals, Inc. (NUSMF)

OTC Markets, PennyStockTweets, Stockhouse, Equities, Marketwired, InvestorsHub, Barchart, Junior Mining Network, The Street, MarketWatch, and YCharts reported previously on Nautilus Minerals, Inc. (NUSMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nautilus Minerals, Inc. is the first company to explore the ocean floor for polymetallic Seafloor Massive Sulphide (SMS) deposits. Nautilus is developing a production system utilizing existing technologies adapted from the offshore oil and gas industry, dredging and mining industries to enable the extraction of these high-grade SMS systems on a commercial scale.

Nautilus Minerals has offices in Brisbane, Australia; Canada; and in Kavieng, New Ireland, Papua New Guinea, and Nuku'alofa, Tonga, South Pacific.

A seafloor resource exploration business, Nautilus explores and develops the ocean floor for copper, gold, silver, and zinc SMS deposits. Furthermore, the Company explores for manganese, nickel, copper, and cobalt nodule deposits. Nautilus has its copper-gold project named Solwara 1. It is under development in the territorial waters of Papua New Guinea (PNG).

The Solwara 1 deposit sits on the seafloor at a water depth of about 1600 meters. Solwara 1 contains a copper grade of approximately 7 percent. This compares with land-based copper mines, where the copper grade today averages 0.6 percent.

Gold grades of substantially more than 20 g/tonne have been recorded in some intercepts at Solwara 1. The average grade is roughly 6 g/tonne. Moreover, the Company holds highly prospective exploration acreage in the western Pacific (granted and under application), and in international waters in the Central Pacific.

Nautilus Minerals is currently negotiating the terms of an agreement with arm's length third parties. This would involve the establishment of a new joint venture company (the Vessel JV) to be owned by the third parties and Nautilus’ subsidiary, Nautilus Minerals Niugini Limited (NMN).

The purpose of the Vessel JV would be to fund the acquisition of the Production Support Vessel (PSV) that Nautilus had previously arranged to be obtained through MAC Goliath Pte Ltd (MAC) and the integration expenses of installing the mining equipment on the PSV. The Vessel JV would own and operate the fully integrated PSV.

Recently, Nautilus Minerals announced that it and Deep Sea Mining Finance Ltd. agreed to extend the maturity date of the existing secured loan facility that is currently due on February 8, 2019, for 28 days ending on March 8, 2019.

Nautilus continues to seek short and long term funding solutions. This is while assessing its options, including different restructuring options. Negotiations with various third parties continue.

Nautilus Minerals, Inc. (NUSMF), closed Wednesday's trading session at $0.001, up 900%, on 11,205 volume with 2 trades. The average volume for the last 3 months is 48,375 and the stock's 52-week low/high is $0.000001999/$0.100000001.

chart

A.M. Castle & Co. (CTAM)

Tip Ranks, Stockhouse, GuruFocus, Simply Wall St, Barchart, YCharts, Wallet Investor, StockTwits, Jet Life Penny Stocks, Stockwolf, Penny Stock Hub, MarketWatch, The Street, Morningstar, InvestorsHub, TradingView, Stockwatch, and Whale Wisdom reported earlier on A.M. Castle & Co. (CTAM), and we also report on the Company, here at the QualityStocks Daily Newsletter.

A.M. Castle & Co., together with its subsidiaries, operates as a specialty metals distribution company in the United States, Canada, Mexico, and internationally. As of March 13, 2018, it operated 22 metals service centers. A.M. Castle distributes engineered specialty grades and alloys of metals. Additionally, the Company offers specialized processing services. OTCQX-listed, A.M. Castle has its head office in Oak Brook, Illinois.

The Company also performs varied specialized fabrications for its customers through subcontractors, which thermally process, turn, polish, and straighten alloy and carbon bars. A. M. Castle primarily serves Fortune 500 companies, and medium and smaller sized firms operating in the producer durable equipment, aerospace, heavy industrial equipment, industrial goods, construction equipment, and retail sectors.

The Company works with worldwide original equipment manufacturers (OEMs) to better serve their multi-location production requirements and delivery needs. Also, A.M. Castle help the thousands of machine shops that service the OEMs or have their own niche end market.

A.M. Castle specializes in the distribution of alloy and stainless steels; nickel alloys; aluminum and carbon. The Company’s products include alloy, aluminum, nickel, stainless steel, carbon, and titanium in plate, sheet, extrusions, and round bar. Furthermore, its products include hexagon bar, square and flat bar, tubing, and coil forms.

A.M. Castle’s H-A Industries is a state-of-the art heat-treat and bar processing facility. H-A Industries provides a wide spectrum of thermal treating and finishing services. The Company also offers a complete range of value-added processing services for plate, sheet, tubing and bar products from locations throughout its network.

Concerning Oil & Gas, A.M. Castle’s metallurgical and supply chain expertise helps oil and gas customers meet unique specifications with stable supplies. Regarding Machine Shops, the Company can help a business operate efficiently and competitively. It accomplishes this through local facilities, first-rate inventory, as well as advanced processing.

Pertaining to Aerospace, A.M. Castle helps aerospace and defense companies navigate complex requirements, schedules, and subcontractor networks. Regarding Industrial, the Company customizes supply plans to customers across industrial sectors - from heavy equipment to semiconductors.

Recently, A. M. Castle & Co. announced that it qualified to trade on the OTCQX® Best Market after formerly trading on the OTCQB® Venture Market. The OTCQX® Best Market is reserved for companies meeting high financial standards, adhering to best corporate governance and compliance practices and requires a professional third-party sponsor introduction.

Chairman and Chief Executive Officer, Mr. Steve Scheinkman of A. M. Castle & Co. said, “Upgrading to OTCQX evidences A. M. Castle’s successful transformation since completing our financial restructuring in 2017. Moreover, we have now demonstrated an ability to generate positive EBITDA in excess of cash interest and are continuing to focus on improving the profitability of our core operations and executing strategic growth initiatives.”

A.M. Castle & Co. (CTAM), closed Wednesday's trading session at $7.00, up 282.5137%, on 886 volume with 7 trades. The average volume for the last 3 months is 1,046 and the stock's 52-week low/high is $1.58000004/$7.00.

chart

Bemax, Inc. (BMXC)

Penny Investor Network, StockRockandRoll, PennyStockLocks, Penny Stock Tweets, Stock Guru, Insider Financial, and ResearchOTC reported on Bemax, Inc. (BMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2012, Bemax, Inc. is a growing global distributor of Disposable Baby Diapers. The Company exports and distributes Disposable Baby Diapers from the United States to developing markets in Africa and Europe. In addition, it exports its private label brands from manufacturers in Asia and distributes to other growing markets. Listed on the OTCQB, Bemax is based in Dallas, Georgia.

The Company’s commitment is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. Its current emphasis is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.

Bemax is pursuing opportunities in the fast-growing international Consumer Staples and Household Products Industries. The Company focuses on business development and mentoring. It synergizes these models into the household products industry.

Bemax announced in 2017 that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). With this agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC. NADC is a foremost U.S. manufacturer of value-priced, eco-friendly disposable baby diapers.

Bemax announced this past April that it filed for trademark with the U.S. Patent & Trademark Office (USPTO) for its brand of Mother's Touch disposable diapers. The Company officially filed for trademark on April 28, 2018 (Serial Number 87899104).

Bemax previously announced that its private label brands of sanitary pads and baby wipes would be available for sales commencing this month. The new Bemax private label brands are available on Walmart.com and on bemaxinc.com/webstore.

Shipment of the Company’s new private label brands to wholesalers and distributors started last month. Furthermore, Bemax will extend sales of its private label to other online selling platforms including target.com to support and grow online sales.

Bemax, Inc. (BMXC), closed Wednesday's trading session at $0.0002, up 100%, on 4,000,000 volume with 3 trades. The average volume for the last 3 months is 8,711,323 and the stock's 52-week low/high is $0.000099999/$0.0012.

chart

Spotlight Innovation, Inc. (STLT)

Penny Picks, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to unique and proprietary platform technology candidates. Its emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.

The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. Spotlight Innovation is based in Urbandale, Iowa.

Spotlight Innovation’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is attained through its extensive relationships with numerous leading academic institutions and other sources. Spotlight provides value-added development capability and funding to expedite development progress.

The Company’s development pipeline includes product candidates for cancer, chronic pain, spinal muscular atrophy (SMA) and Zika virus infection. Spotlight works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. Additionally, it works to provide value-added development capability and funding to achieve fast IND approval to commence human clinicals for targeted Platform Technology Candidates.       

Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive global rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.

Spotlight Innovation subsidiary Caretta Therapeutics has its chronic pain relief product Venodol Roll-on. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.

Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, started Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. Contract Research Organization (CRO) ImmunoClin Ltd. is supervising the study conduct.

Spotlight Innovation has entered into a multi-year partnership agreement with Hip-Hope, Inc. (Des Moines, Iowa-based), an organization committed to using arts and culture to promote, advocate and support hope for at-risk youth wherever symptoms of hopelessness are widespread.

As part of this partnership, Spotlight Innovation is the title sponsor for Hip-Hope’s 2018 “#kidslivesmatter FUNraiser Challenge” to take place August 3, 2018, at the 7 Flags Event Center in Clive, Iowa. The annual event is a youth empowerment campaign. The design of it is to build kids’ character, physical health, as well as self-esteem.

Recently, Spotlight Innovation announced that Company research collaborator Professor Kevin Hodgetts was awarded a grant of $300,000 by the nonprofit organization Cure SMA for the project Pre-Clinical Development of LDN-5178 for the Treatment of SMA.

Spotlight Innovation holds an exclusive, worldwide development and commercialization license from Indiana University Innovation and Commercialization Office for LDN-5178 and a group of related compounds. This includes STL-182.

Spotlight Innovation, Inc. (STLT), closed Wednesday's trading session at $0.016, up 99.5012%, on 2,024 volume with 3 trades. The average volume for the last 3 months is 8,711,323 and the stock's 52-week low/high is $0.002/$0.039999999.

chart

The QualityStocks Company Corner

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, recently announced a couple of important moves in line with its corporate expansion and vertical integration CBD market strategy.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Wednesday's trading session at $0.0021, off by 4.5455%, on 20,680,513 volume with 147 trades. The average volume for the last 3 months is 13,710,578 and the stock's 52-week low/high is $0.0012/$0.14.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. ("Siyata") (TSX-V:SIM / OTCQX:SYATF) is pleased to announce it has completed network approval of the Company’s flagship Uniden(R) UV350  in-vehicle phablet with an additional Tier 1 cellular carrier in Canada and anticipates commercial launch in Q3, adding to its growing list of nationwide cellular carrier partnerships in North America.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Wednesday's trading session at $0.365, up 3.8832%, on 22,250 volume with 8 trades. The average volume for the last 3 months is 54,862 and the stock's 52-week low/high is $0.288599997/$0.446249991.

Recent News

chart

City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

City View Green Holdings Inc. (CSE: CVGR) (formerly Icon Exploration Inc.) (the "Company" or "City View Green") trading through the facilities of the Canadian Securities Exchange ("CSE") under the symbol "CVGR" at the request of IIROC, City View Green wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed Wednesday's trading session at $0.125, up 13.64%, on 303,770 volume with 38 trades. The average volume for the last 3 months is 104,194 and the stock's 52-week low/high is $0.094999998/$0.465000003.

Recent News

chart

Grapefruit Boulevard Investments Inc. (IGNG)

The QualityStocks Daily Newsletter would like to spotlight Grapefruit Boulevard Investments Inc., the wholly owned subsidiary of Imaging3 Inc. (IGNG).

Grapefruit Boulevard Investments Inc. (OTCQB: IGNG), a fully licensed cannabis manufacturer and distributor in California, is fast becoming recognized in the industry for its quality product lines. Those products – including Rainbow Dreams, Grapefruit’s most recent offering – adhere strictly to the company’s motto and commitment to offer “a high you can trust.”

Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.

The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.

Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.

Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.

Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.

The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.

Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.

The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.

Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.

Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.

Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.

Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:

  • Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
  • Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.

Grapefruit Boulevard Investments Inc. (IGNG), closed Wednesday's trading session at $0.077, up 2.5983%, on 19,852 volume with 20 trades. The average volume for the last 3 months is 134,743 and the stock's 52-week low/high is $0.006095/$0.358999997.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions, Inc. (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, has reported financial results for the fiscal period ended June 30, 2019.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Wednesday's trading session at $0.06, up 29.8701%, on 70,801 volume with 10 trades. The average volume for the last 3 months is 134,743 and the stock's 52-week low/high is $0.032000001/$2.5999999.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) was featured today in a report by Potstocknews.com, examining how, in February, the World Health Organization recommended that the United Nations remove pot and its key components from a list of highly-controlled substances under international drug treaties. Since then, there has been rapid development towards regulation and capitalization of pot-related industries, especially in Europe.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $5.37, off by 3.5907%, on 902,981 volume with 3,376 trades. The average volume for the last 3 months is 1,062,282 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today reported financial results for the second quarter and six months ended June 30, 2019. Steve Wallach, Chairman and CEO of Youngevity International stated, "We are pleased with our quarter over quarter revenue growth and we are encouraged by the increase in gross profits and in Adjusted EBITDA over Q2 2018.  We are making progress toward stabilizing revenues in our direct selling segment and this combined with strong revenue delivered by our commercial coffee segment has provided our second consecutive quarter of Q over Q growth." Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed Wednesday's trading session at $4.93, off by 4.0856%, on 102,557 volume with 720 trades. The average volume for the last 3 months is 98,312 and the stock's 52-week low/high is $3.56999993/$16.25.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Stock Day Media prides itself in discovering companies with highly talented staff, revolutionary technologies, and the experience to combine these two key assets to change an industry. We have been watching an intriguing company for several years now, and with the news they recently released, we believe they are truly a company that has the talent, technology, experience, patent protection, and know-how to change an industry. The company is Pressure BioSciences, Inc. (OTCQB: PBIO), the industry is cannabis, and their patented platform is called Ultra Shear Technology™, or UST™.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $2.46, off by 5.0193%, on 3,943 volume with 19 trades. The average volume for the last 3 months is 8,979 and the stock's 52-week low/high is $1.51999998/$4.0999999.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in a report by Potstocknews.com, examining how, amidst reports that the CBD industry on the continent is exploding—with the Brightfield group projecting that in Europe the market will grow more 400% through 2023—there is remarkable room for growth in the CBD space.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Wednesday's trading session at $2.36, off by 14.4928%, on 1,738,229 volume with 1,922 trades. The average volume for the last 3 months is 8,979 and the stock's 52-week low/high is $1.60699999/$7.89379978.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., successfully completed a controlled-environment trial of its Eye-Net™ cellular-based accident prevention solution for a leading vehicle manufacturer. The trial, conducted in a designated test track, was designed to demonstrate Eye-Net’s advanced capabilities of protecting vehicles and vulnerable road users from oncoming collisions, to test the system’s performance and robustness, and to discuss possible suitability of the Eye-Net solution for the connected car platforms of the leading vehicle manufacturer.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Wednesday's trading session at $1.53, off by 6.7073%, on 117,684 volume with 201 trades. The average volume for the last 3 months is 533,257 and the stock's 52-week low/high is $0.697000026/$3.16000008.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN)  (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has executed a definitive purchase agreement (the "SPA") for all of the outstanding equity interest in Tres Ojos Naturals LLC, doing business as SolDaze, a limited liability company based in Santa Cruz, California. The transaction will absorb SolDaze's branding asset package into the Company's expanding asset portfolio, which the Company believes will provide significant penetration into the cannabis market in California. SolDaze is an operating company producing and selling the only all-natural cannabis-infused fruit snack in California.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed Wednesday's trading session at $1.10, off by 3.51%, on 109,533 volume with 69 trades. The average volume for the last 3 months is 141,020 and the stock's 52-week low/high is $0.76999998/$7.78999996.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Tuesday announced the closing of its acquisition of all of the issued and outstanding shares of privately-held Truverra Inc. According to the update, the transaction was completed by way of a three-cornered amalgamation. To view the full press release, visit: http://nnw.fm/3AE7e.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $1.03, off by 5.3309%, on 604,787 volume with 567 trades. The stock's 52-week low/high is $0.850000023/$2.03999996.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Brian Quigley to its board of directors. Mr. Quigley most recently spent 16 years at Altria Group, with 7 of those years spent as President and Chief Executive Officer for U.S. Smokeless Tobacco and Nu-Mark, Altria's innovation company, during the time that the existing business relationship between Altria and Lexaria was negotiated.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.8001, off by 5.8706%, on 83,108 volume with 244 trades. The average volume for the last 3 months is 73,506 and the stock's 52-week low/high is $0.600000023/$2.24.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTCQB: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts (CBD), as well as electronic cigarettes containing nicotine, will begin quotation on the OTCQB Venture Market today.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Wednesday's trading session at $0.039536, off by 19.1493%, on 251,555 volume with 18 trades. The average volume for the last 3 months is 58,533 and the stock's 52-week low/high is $0.035/$0.119999997.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.